Minggui Pan, MD, PhD
Publications
A Multicenter Virtual Multidisciplinary Sarcoma Case Conference Improves Outcome for a Rare Soft Tissue Sarcoma (Dermatofibrosarcoma Protuberans)
Authors: Chang, Amber L;Kwak, Hyunjee V;Pan, Minggui;Peng, Peter D;Morse, Lee J;Chang, C K
Am Surg. 2023 Dec;89(12):5240-5245. Epub 2022-11-28.
Sex- and Co-Mutation-Dependent Prognosis in Patients with SMARCA4-Mutated Malignancies
Authors: Pan, Minggui;Jiang, Chen;Zhang, Zheyang;Achacoso, Ninah;Solorzano-Pinto, Aleyda V;Tse, Pam;Chung, Elaine;Suga, Jennifer Marie;Thomas, Sachdev;Habel, Laurel A
Cancers (Basel). 2023 May 09;15(10). Epub 2023-05-09.
TP53 Gain-of-Function and Non-Gain-of-Function Mutations Are Associated With Differential Prognosis in Advanced Pancreatic Ductal Adenocarcinoma
Authors: Pan, Minggui;Achacoso, Ninah;Thomas, Sachdev;Habel, Laurel A;et al.
JCO Precis Oncol. 2023 May;7:e2200570.
High-dimensional single-cell analysis unveils distinct immune signatures of peripheral blood in patients with pancreatic ductal adenocarcinoma
Authors: Pan, Yu;Gao, Jianfeng;Lin, Jiajing;Ma, Yuan;Hou, Zelin;Lin, Yali;Wen, Shi;Pan, Minggui;Lu, Fengchun;Huang, Heguang
Front Endocrinol (Lausanne). 2023;14:1181538. Epub 2023-06-06.
Pain as Initial Presenting Symptom Is Associated With Delay to Seeking Medical Attention, Higher Risk of Relapse, and Shorter Survival in Patients With Early-Stage Extremity or Trunk Synovial Sarcoma
Authors: Seto, Tiffany; Merchant, Maqdooda; Morse, Lee Jae; Fang, Andrew; Song, Mee-Na; Russell, Elisabeth A; Pan, Minggui
Perm J. 2022 Sep 14;26(3):94-102. Epub 2022-08-01.
Impact of a Virtual Multidisciplinary Sarcoma Case Conference on Treatment Plan and Survival in a Large Integrated Healthcare System
Authors: Pan, Minggui; Yu, Jeanette; Sidhu, Manpreet; Seto, Tiffany; Fang, Andrew
JCO Oncol Pract. 2021 11;17(11):e1711-e1718. Epub 2021-04-14.
Rapid Response of a BRCA2/TP53/PTEN-Deleted Metastatic Uterine Leiomyosarcoma to Olaparib: A Case Report
Authors: Pan, Minggui; Ganjoo, Kristen; Karam, Amer
Perm J. 2021 05;25.
Fourteen-Day Gemcitabine-Docetaxel Chemotherapy Is Effective and Safer Compared to 21-Day Regimen in Patients with Advanced Soft Tissue and Bone Sarcoma
Authors: Pan, Minggui; Trieu, Maily K; Sidhu, Manpreet; Yu, Jeanette; Seto, Tiffany; Ganjoo, Kristen
Cancers (Basel). 2021 Apr 20;13(8). Epub 2021-04-20.
Complete Regression of Rhabdomyosarcoma in an Adult Secondary to Postoperative Wound Infection Following Limb Salvage Surgery: A Case Report
Authors: Fang, Andrew S; Morse, Lee Jae; Wustrack, Rosanna; Huber, Ryan; Pan, Minggui
Perm J. 2020 12;25:1.
Durable Complete Remission of PD-L1 Positive NUT Carcinoma Treated With Concurrent Chemotherapy and Radiation
Authors: Pan, Minggui; Chang, James S
Perm J. 2020 12;25:1-3.
Feasibility and Value of Establishing a Community-Based Virtual Multidisciplinary Sarcoma Case Conference
Authors: Pan, Minggui; Zou, Youran; et al.
JCO Oncol Pract. 2020 10;16(10):e1143-e1150.
Feasibility and Value of Establishing a Community-Based Virtual Multidisciplinary Sarcoma Case Conference
Authors: Pan M; Zou Y; et al.
JCO Oncol Pract. 2020 Jun 12:OP2000110.
Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer
Authors: Pan Y; Pan M; Huang H; et al.
J Hematol Oncol. 2019 11 27;12(1):124. Epub 2019-11-27.
Case series of MET exon 14 skipping mutation-positive non-small-cell lung cancers with response to crizotinib and cabozantinib
Authors: Wang SXY; Zhang BM; Wakelee HA; Koontz MZ; Pan M; Diehn M; Kunder CA; Neal JW
Anticancer Drugs. 2019 06;30(5):537-541.
Real-World Experiences with Pazopanib in Patients with Advanced Soft Tissue and Bone Sarcoma in Northern California
Authors: Seto T; Song MN; Trieu M; Yu J; Sidhu M; Liu CM; Sam D; Pan M
Med Sci (Basel). 2019 Mar 18;7(3). Epub 2019-03-18.
Mechanisms of Primary and Secondary Resistance to Immune Checkpoint Inhibitors in Cancer
Authors: Seto T; Sam D; Pan M
Med Sci (Basel). 2019 Jan 22;7(2). Epub 2019-01-22.
Synergistic inhibition of pancreatic cancer with anti-PD-L1 and c-Myc inhibitor JQ1
Authors: Pan Y; Fei Q; Xiong P; Yang J; Zhang Z; Lin X; Pan M; Lu F; Huang H
Oncoimmunology. 2019;8(5):e1581529. Epub 2019-03-01.
WIPF1 antagonizes the tumor suppressive effect of miR-141/200c and is associated with poor survival in patients with PDAC
Authors: Pan Y; Lu F; Xiong P; Pan M; Zhang Z; Lin X; Pan M; Huang H
J Exp Clin Cancer Res. 2018 Jul 24;37(1):167. Epub 2018-07-24.
Association of Inflammatory Markers with Disease Progression in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibitors
Authors: Pan M; Alavi M; Herrinton LJ
Perm J. 2018 Mar 30;22.
Risk Factors Including Age, Stage and Anatomic Location that Impact the Outcomes of Patients with Synovial Sarcoma
Authors: Pan M; Merchant M
Med Sci (Basel). 2018 Mar 06;6(1). Epub 2018-03-06.
Histologic Grade Is Predictive of Incidence of Epidermal Growth Factor Receptor Mutations in Metastatic Lung Adenocarcinoma
Authors: Levy M; Lyon L; Barbero E; Wong J; Suga M; Sam D; Pan M
Med Sci (Basel). 2017 Dec 11;5(4). Epub 2017-12-11.
Study of Arsenic Sulfide in Solid Tumor Cells Reveals Regulation of Nuclear Factors of Activated T-cells by PML and p53
Authors: Ding W; Tong Y; Zhang X; Pan M; Chen S
Sci Rep. 2016 Jan 22;6:19793. Epub 2016-01-22.
Arsenic sulfide combined with JQ1, chemotherapy agents, or celecoxib inhibit gastric and colon cancer cell growth
Authors: Zhang L; Tong Y; Zhang X; Pan M; Chen S
Drug Des Devel Ther. 2015;9:5851-62. Epub 2015-10-30.
